DIFFERENTIAL ROLE OF INTERFERON-GAMMA IN THE POTENTIATING EFFECT OF MURAMYL PEPTIDES FOR ENHANCED RESPONSES TO LIPOPOLYSACCHARIDE IN MICE - EFFECT OF CYCLOSPORINE-A

被引:4
作者
BEIGNEUX, A
HUANG, J
LECONTEL, C
HEREMANS, H
PARANT, MA
机构
[1] LAB IMMUNOPHARMACOL,CNRS,F-75270 PARIS 06,FRANCE
[2] UNIV PARIS 06,F-75270 PARIS 06,FRANCE
[3] CATHOLIC UNIV LEUVEN,REGA INST,IMMUNOBIOL LAB,B-3000 LOUVAIN,BELGIUM
关键词
D O I
10.1089/jir.1995.15.359
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cyclosporin A (CsA) administration reduced mortality in mice sensitized to endotoxic toxicity by various agents, such as muramyl dipeptide (MDP) or a lipophilic derivative. CsA is an inhibitor of a variety of T cell responses, suggesting that muramyl peptides could influence LPS-induced effects via the release of lymphokine, The potentiation of TNF production by pretreatment with muramyl peptides was comparable in nude mice and in controls, indicating that it is a T-independent mechanism, and CsA produced a similar inhibition in both groups. Neutralizing antibody to IFN-gamma did not change the elevated TNF level obtained in the blood when LPS was given after a muramyl peptide, However, the same treatment with anti-IFN-gamma MAb prevented the death of mice challenged with LPS plus MDP or plus a lipophilic derivative displaying similar effects, In comparing three selected muramyl peptides, we also show that the priming effect could be dissociated from the toxic synergism with LPS.
引用
收藏
页码:359 / 365
页数:7
相关论文
共 40 条
[1]   THE MODULATION OF TUMOR-NECROSIS-FACTOR-ALPHA, INTERLEUKIN-1-ALPHA AND GLUCOSE-LEVELS WITH GMDP AND OTHER ANALOGS OF MURAMYL DIPEPTIDE [J].
ADELEYE, TA ;
MORENO, C ;
IVANYI, J ;
ASTON, R .
APMIS, 1994, 102 (02) :145-152
[2]   A RECOMBINANT HUMAN RECEPTOR ANTAGONIST TO INTERLEUKIN-1 IMPROVES SURVIVAL AFTER LETHAL ENDOTOXEMIA IN MICE [J].
ALEXANDER, HR ;
DOHERTY, GM ;
BURESH, CM ;
VENZON, DJ ;
NORTON, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (04) :1029-1032
[3]   ANTI-INTERFERON-GAMMA ANTIBODY PROTECTS MICE AGAINST THE GENERALIZED SHWARTZMAN REACTION [J].
BILLIAU, A ;
HEREMANS, H ;
VANDEKERCKHOVE, F ;
DILLEN, C .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1987, 17 (12) :1851-1854
[4]  
Buetler B., 1985, SCIENCE, V229, P869
[5]   BIOLOGICAL-ACTIVITY OF A NEW SYNTHETIC MURAMYL PEPTIDE ADJUVANT DEVOID OF PYROGENICITY [J].
CHEDID, LA ;
PARANT, MA ;
AUDIBERT, FM ;
RIVEAU, GJ ;
PARANT, FJ ;
LEDERER, E ;
CHOAY, JP ;
LEFRANCIER, PL .
INFECTION AND IMMUNITY, 1982, 35 (02) :417-424
[6]  
COCKFIELD SM, 1993, J IMMUNOL, V150, P717
[7]  
COCKFIELD SM, 1993, J IMMUNOL, V150, P342
[8]  
DOHERTY GM, 1992, J IMMUNOL, V149, P1666
[9]   INVIVO INDUCTION OF INTERLEUKIN-10 BY ANTI-CD3 MONOCLONAL-ANTIBODY OR BACTERIAL LIPOPOLYSACCHARIDE - DIFFERENTIAL MODULATION BY CYCLOSPORINE-A [J].
DUREZ, P ;
ABRAMOWICZ, D ;
GERARD, C ;
VANMECHELEN, M ;
AMRAOUI, Z ;
DUBOIS, C ;
LEO, O ;
VELU, T ;
GOLDMAN, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :551-555
[10]  
FREUDENBERG MA, 1993, BACTERIAL ENDOTOXINS, P197